Internal Medicine Board Review: Anticoagulation in atrial fibrillation - CHADS2 vs CHA2DS2-VASc

2,487 views

Published on

ABIM internal medicine exam review: Patients with atrial fibrillation should be stratified according to their risk of stroke so that they can be placed on the appropriate antithrombotic regimen. A simple clinical tool to perform this risk stratification is the CHADS2 score. A revised extension of the CHA2DS2-VASc score has been developed and has shown incremental improvement in the classification of a patient’s risk.

Published in: Education
0 Comments
7 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
2,487
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
30
Comments
0
Likes
7
Embeds 0
No embeds

No notes for slide

Internal Medicine Board Review: Anticoagulation in atrial fibrillation - CHADS2 vs CHA2DS2-VASc

  1. 1. IntellectualPropertyofKnowmedge.com Anticoagulation in Atrial Fibrillation C H A D S2 Congestive Heart Failure Hypertension Age ≥75 years Diabetes Mellitus Stroke (or TIA) CHADS2 0 1 2 Aspirin 325mg Aspirin 325mg Anticoagulation 3 6 or Anticoagulation C H A2 D S2 Congestive Heart Failure Hypertension Age ≥75 years Diabetes Mellitus Stroke (or TIA) V A Sc Vascular Disease Age 65-74 years Sex category (Female)

×